More on the use of bisphosphonates in the prevention and treatment of osteoporosis

BMJ. 2015 Nov 4:351:h5868. doi: 10.1136/bmj.h5868.

Authors

Salvatore Minisola¹, Cristiana Cipriani², Alfredo Scillitani³, Jessica Pepe²

Affiliations

¹ Department of Internal Medicine and Medical Disciplines "Sapienza," Rome University, Rome, Italy salvatore.minisola@uniroma1.it.
² Department of Internal Medicine and Medical Disciplines "Sapienza," Rome University, Rome, Italy.
³ Unit of Endocrinology, "Casa Sollievo della Sofferenza" Hospital, IRCCS, San Giovanni Rotondo (FG), Italy.

PMID: 26538380
DOI: 10.1136/bmj.h5868

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents / therapeutic use*
Diphosphonates / therapeutic use*
Female
Humans
Osteoporosis / drug therapy*
Osteoporosis / prevention & control*

Substances

Bone Density Conservation Agents
Diphosphonates